InVivo Therapeutics Holdings Past Earnings Performance
Past criteria checks 0/6
InVivo Therapeutics Holdings has been growing earnings at an average annual rate of 17.1%, while the Medical Equipment industry saw earnings growing at 11.3% annually.
Key information
17.1%
Earnings growth rate
99.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | n/a |
| Return on equity | -104.6% |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
InVivo Therapeutics dips 24% on $9M direct and private placement offerings
Oct 07We're Not Very Worried About InVivo Therapeutics Holdings' (NASDAQ:NVIV) Cash Burn Rate
Aug 26
Is InVivo Therapeutics Holdings (NASDAQ:NVIV) In A Good Position To Invest In Growth?
May 05Will InVivo Therapeutics Holdings (NASDAQ:NVIV) Spend Its Cash Wisely?
Jan 18Revenue & Expenses BreakdownBeta
How InVivo Therapeutics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -9 | 6 | 4 |
| 30 Jun 23 | 0 | -9 | 5 | 5 |
| 31 Mar 23 | 0 | -10 | 5 | 5 |
| 31 Dec 22 | 0 | -10 | 5 | 5 |
| 30 Sep 22 | 0 | -11 | 6 | 5 |
| 30 Jun 22 | 0 | -11 | 6 | 5 |
| 31 Mar 22 | 0 | -10 | 6 | 5 |
| 31 Dec 21 | 0 | -10 | 6 | 4 |
| 30 Sep 21 | 0 | -9 | 5 | 4 |
| 30 Jun 21 | 0 | -9 | 5 | 4 |
| 31 Mar 21 | 0 | -9 | 5 | 4 |
| 31 Dec 20 | 0 | -9 | 5 | 4 |
| 30 Sep 20 | 0 | -10 | 5 | 4 |
| 30 Jun 20 | 0 | -11 | 5 | 5 |
| 31 Mar 20 | 0 | -12 | 6 | 6 |
| 31 Dec 19 | 0 | -12 | 6 | 6 |
| 30 Sep 19 | 0 | -11 | 6 | 6 |
| 30 Jun 19 | 0 | -11 | 6 | 5 |
| 31 Mar 19 | 0 | -21 | 6 | 5 |
| 31 Dec 18 | 0 | -23 | 8 | 5 |
| 30 Sep 18 | 0 | -26 | 9 | 5 |
| 30 Jun 18 | 0 | -32 | 12 | 6 |
| 31 Mar 18 | 0 | -25 | 13 | 8 |
| 31 Dec 17 | 0 | -27 | 13 | 10 |
| 30 Sep 17 | 0 | -28 | 13 | 13 |
| 30 Jun 17 | 0 | -24 | 13 | 14 |
| 31 Mar 17 | 0 | -23 | 12 | 13 |
| 31 Dec 16 | 0 | -23 | 12 | 13 |
| 30 Sep 16 | 0 | -23 | 11 | 11 |
| 30 Jun 16 | 0 | -19 | 12 | 11 |
| 31 Mar 16 | 0 | -24 | 12 | 10 |
| 31 Dec 15 | 0 | -33 | 12 | 10 |
| 30 Sep 15 | 0 | -37 | 12 | 9 |
| 30 Jun 15 | 0 | -36 | 10 | 9 |
| 31 Mar 15 | 0 | -29 | 9 | 10 |
| 31 Dec 14 | 0 | -18 | 8 | 11 |
| 30 Sep 14 | 0 | -16 | 7 | 12 |
| 30 Jun 14 | 0 | -20 | 8 | 13 |
| 31 Mar 14 | 0 | -31 | 9 | 13 |
| 31 Dec 13 | 0 | -39 | 8 | 12 |
| 30 Sep 13 | 0 | -42 | 8 | 11 |
Quality Earnings: NVIV.Q is currently unprofitable.
Growing Profit Margin: NVIV.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NVIV.Q is unprofitable, but has reduced losses over the past 5 years at a rate of 17.1% per year.
Accelerating Growth: Unable to compare NVIV.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NVIV.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: NVIV.Q has a negative Return on Equity (-104.59%), as it is currently unprofitable.